Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo-controlled, 12-week study in early postmenopausal women - Post,M.S.; Hendriks,D.F.; van der Mooren,J.M. (J Intern Med, 2002)